389 related articles for article (PubMed ID: 26219895)
1. C14ORF166 overexpression is associated with pelvic lymph node metastasis and poor prognosis in uterine cervical cancer.
Zhang W; Ou J; Lei F; Hou T; Wu S; Niu C; Xu L; Zhang Y
Tumour Biol; 2016 Jan; 37(1):369-79. PubMed ID: 26219895
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of chromosome 14 open reading frame 166 correlates with disease progression and poorer prognosis in human NPC.
Yang L; Li F; Lei F; Wang Y; Wu S; Song L; Chen Y
Tumour Biol; 2015 Sep; 36(10):7977-86. PubMed ID: 25964093
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of eukaryotic initiation factor 5A2 (EIF5A2) is associated with cancer progression and poor prognosis in patients with early-stage cervical cancer.
Yang SS; Gao Y; Wang DY; Xia BR; Liu YD; Qin Y; Ning XM; Li GY; Hao LX; Xiao M; Zhang YY
Histopathology; 2016 Aug; 69(2):276-87. PubMed ID: 26799253
[TBL] [Abstract][Full Text] [Related]
4. B3GNT3 Expression Is a Novel Marker Correlated with Pelvic Lymph Node Metastasis and Poor Clinical Outcome in Early-Stage Cervical Cancer.
Zhang W; Hou T; Niu C; Song L; Zhang Y
PLoS One; 2015; 10(12):e0144360. PubMed ID: 26709519
[TBL] [Abstract][Full Text] [Related]
5. NR2F6 Expression Correlates with Pelvic Lymph Node Metastasis and Poor Prognosis in Early-Stage Cervical Cancer.
Niu C; Sun X; Zhang W; Li H; Xu L; Li J; Xu B; Zhang Y
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775588
[TBL] [Abstract][Full Text] [Related]
6. Aberrant TIMELESS expression is associated with poor clinical survival and lymph node metastasis in early-stage cervical carcinoma.
Zhang W; He W; Shi Y; Zhao J; Liu S; Zhang F; Yang J; Xie C; Zhang Y
Int J Oncol; 2017 Jan; 50(1):173-184. PubMed ID: 27909716
[TBL] [Abstract][Full Text] [Related]
7. Expression and clinical significance of C14orf166 in esophageal squamous cell carcinoma.
Zhou YW; Li R; Duan CJ; Gao Y; Cheng YD; He ZW; Zeng JX; Zhang CF
Mol Med Rep; 2017 Feb; 15(2):605-612. PubMed ID: 28000881
[TBL] [Abstract][Full Text] [Related]
8. Overexpressed C14orf166 associates with disease progression and poor prognosis in non-small-cell lung cancer.
Zhou YW; Li R; Duan CJ; Gao Y; Cheng YD; Zhang CF
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30126850
[TBL] [Abstract][Full Text] [Related]
9. CPE overexpression is correlated with pelvic lymph node metastasis and poor prognosis in patients with early-stage cervical cancer.
Shen HW; Tan JF; Shang JH; Hou MZ; Liu J; He L; Yao SZ; He SY
Arch Gynecol Obstet; 2016 Aug; 294(2):333-42. PubMed ID: 26695643
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of serum squamous cell carcinoma antigen in patients with early cervical squamous cell carcinoma].
Li D; Xu XX; Yan DD; Yuan SH; Lou HM
Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):357-362. PubMed ID: 31137169
[No Abstract] [Full Text] [Related]
11. C14orf166 overexpression correlates with tumor progression and poor prognosis of breast cancer.
Cheang TY; Zhou HY; Chen W; Zhang B; Liu L; Yang J; Wang S; Li H
J Transl Med; 2016 Feb; 14():54. PubMed ID: 26883017
[TBL] [Abstract][Full Text] [Related]
12. High Expression of KIF20A Is Associated with Poor Overall Survival and Tumor Progression in Early-Stage Cervical Squamous Cell Carcinoma.
Zhang W; He W; Shi Y; Gu H; Li M; Liu Z; Feng Y; Zheng N; Xie C; Zhang Y
PLoS One; 2016; 11(12):e0167449. PubMed ID: 27941992
[TBL] [Abstract][Full Text] [Related]
13. DLL4 as a predictor of pelvic lymph node metastasis and a novel prognostic biomarker in patients with early-stage cervical cancer.
Yang S; Liu Y; Xia B; Deng J; Liu T; Li Q; Yang Y; Wang Y; Ning X; Zhang Y; Xiao M
Tumour Biol; 2016 Apr; 37(4):5063-74. PubMed ID: 26546434
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA activated by transforming growth factor-β promotes cancer development and is a prognostic marker in cervical cancer.
Cao W; Peng T; Zhou Y
J Cancer Res Ther; 2017; 13(5):801-806. PubMed ID: 29237907
[TBL] [Abstract][Full Text] [Related]
15. CISD2 expression is a novel marker correlating with pelvic lymph node metastasis and prognosis in patients with early-stage cervical cancer.
Liu L; Xia M; Wang J; Zhang W; Zhang Y; He M
Med Oncol; 2014 Sep; 31(9):183. PubMed ID: 25134919
[TBL] [Abstract][Full Text] [Related]
16. Down-regulated serum microRNA-101 is associated with aggressive progression and poor prognosis of cervical cancer.
Jiang W; Pan JJ; Deng YH; Liang MR; Yao LH
J Gynecol Oncol; 2017 Nov; 28(6):e75. PubMed ID: 29027393
[TBL] [Abstract][Full Text] [Related]
17. C14orf166 Is a Biomarker for Predicting Hepatocellular Carcinoma Recurrence.
Chen J; Chen J; Gong Y; Zou B; Liu X; Ding L; Huang J; Zhang B; Li J
J Invest Surg; 2020 Dec; 33(10):914-923. PubMed ID: 30907217
[No Abstract] [Full Text] [Related]
18. C14orf166 is a high-risk biomarker for bladder cancer and promotes bladder cancer cell proliferation.
Chen M; Ye Y; Zou B; Guo S; Zhou F; Lu K; Liu J; Xu Z; Han H; Liu Z; Li Y; Yao K; Liu C; Qin Z
J Transl Med; 2016 Feb; 14():55. PubMed ID: 26905879
[TBL] [Abstract][Full Text] [Related]
19. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
Luo M; Shen D; Wang W; Xian J
Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
[TBL] [Abstract][Full Text] [Related]
20. [Expression of metastasis tumor-associated protein 2 in cervical squamous carcinoma and
its relationship with prognosis].
Xiao L; Huang S; Cheng H; Chen J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 41(10):1031-1038. PubMed ID: 27807324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]